Skip to content
healthcare.dev

LANTIDRA

NDC 73539-001, DONISLECEL, solution, from CellTrans Inc..

Product NDC
73539-001
Status
Listed
Labeler
CellTrans Inc.
Dosage form
SOLUTION
Route
INTRAVASCULAR
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125734
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73539-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DONISLECEL5000 [arb'U]/400mL
Package NDCNDC-11Package
73539-001-0173539000101400 mL in 1 BAG (73539-001-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73539-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73539-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73539-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.